Cerebral arterial occlusive disease with telangiectasia associated with oral contraceptives.
D000328:Adult; D001157:Arterial Occlusive Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000032:analysis; D002533:Cerebral Angiography; D002539:Cerebral Arterial Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D002941:Circle of Willis / Q000000981:diagnostic imaging; D003097:Collateral Circulation; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004569:Electroencephalography; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D006801:Humans; D008656:Mestranol / Q000009:adverse effects; D013684:Telangiectasis / Q000139:chemically induced* / Q000000981:diagnostic imaging
D001779:Blood Coagulation Factors; D003276:Contraceptives, Oral; D005040:Ethynodiol Diacetate; D008656:Mestranol